Adjuvant composition comprising aluminium phosphate and 3D-MPL

Details for Australian Patent Application No. 2006215419 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors O'Hagan, Derek

Agent FB Rice

Pub. Number AU-B-2006215419

PCT Pub. Number WO2006/087563

Priority 60/653,741 16.02.05 US

Filing date 16 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 8 March 2012

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/087563 Priority application(s): WO2006/087563

8 March 2012 Application Accepted

  Published as AU-B-2006215419

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215439-UV inkjet printing of vision control panels

2006215418-Cosmetic method of regenerating the reticular architecture of the dermis